scPharmaceuticals: A Recent IPO With A Novel Drug Delivery Platform

Summary

The company launched an IPO on NASDAQ raising $89.6M (1.4M shares at $14/share) recently.

Its platform is focused on providing subcutaneous delivery of commonly used intravenous drugs, allowing convenient at home administration and early hospital discharge.

We are initiating coverage on the common stock with a Buy rating and first price target=$26.

scPharmaceuticals (Pending:SCPH), a recent IPO on NASDAQ, is based in Burlington, MA. The company launched an IPO on NASDAQ raising $89.6M (1.4M shares at $14/share). Its platform is focused on providing subcutaneous delivery of commonly used intravenous drugs, allowing convenient at home administration and reducing the cost of hospitalization. Early investors in the company include OrbiMed Advisors, Sun Pharmaceuticals, and WellPoint.

☑Read more

عضویت در کانال زیست فن☑

scPharmaceuticals: A Recent IPO With A Novel Drug Delivery Platform

Rate this post
برچسب‌ها
نمایش بیشتر

نوشته‌های مشابه

دیدگاهتان را بنویسید

نشانی ایمیل شما منتشر نخواهد شد. بخش‌های موردنیاز علامت‌گذاری شده‌اند *

دکمه بازگشت به بالا
EnglishIran
بستن
بستن